Deep Lens

Faster recruitment of the best-suited cancer patients for clinical trials at the time of diagnosis.

[Deep Lens @deeplens_ai]

Arere you a healthcare provider or a #cancer studies sponsor? DeepLens presents for you the care that cancer patients need with VIPER, an #AI technology to automate the screening from remote patient identification to qualified enrolment.

Book a demo! https://t.co/mCL36U5MNy

[Deep Lens @deeplens_ai]

"We value our relationship with Deep Lens and are looking forward to being able to roll VIPER out to as many trials as possible."
#clinicalresearch #clinicaltrials #oncology #precisionmedicine #research #genomics

https://t.co/u0648zmOIs

[Deep Lens @deeplens_ai]

|| Download || By identifying patients at the time of diagnosis, our advanced AI-enabled patient recruitment platform compresses study timelines by finding the best-suited patients for clinical trials. Download our brochure to learn more...

https://t.co/9RkmA7v4ll

[Deep Lens @deeplens_ai]

We are at the #ASCO22 Annual Meeting in Chicago, Illinois.
Meet the Deep Lens team there. Leaders across our commercial and clinical operations teams are attending. See you there! @asco
#clinicaltrial #oncology #cancer #AI #clinicalresearch #cancerresearch

[Deep Lens @deeplens_ai]

🔷 Have you registered? Let us know if you will be there at the #ASCO22 Annual Meeting on June 3 - 7, 2022, at McCormick Place, Chicago, Illinois.
Contact us for a meetup; let’s discuss #AI technologies to support the #cancer patients worldwide https://t.co/S7mzPGc1FR

[Deep Lens @deeplens_ai]

We are excited to announce that Deep Lens will be sponsoring #oncology #clinicalresearch global summits. Meet us at @MySCRS Site Solutions Summit on May 20, 2022, and at the Global Oncology Site Solutions Summit, Austin Texas, on May 21 and 22, 2022. https://t.co/ljCsnzM5ou

[Deep Lens @deeplens_ai]

#VIPER identifies and matches patients to precision trials in the narrow window of opportunity through lab-agnostic genomic data ingestion.
Download our brochure to learn more about VIPER technology presented by #DeepLens. 👉https://t.co/XE1rkydUSp

#cancerreaserch #diversity

[Deep Lens @deeplens_ai]

Arere you a healthcare provider or a #cancer studies sponsor? DeepLens presents for you the care that cancer patients need with VIPER, an #AI technology to automate the screening from remote patient identification to qualified enrolment.

Book a demo! https://t.co/sEJVTQUyzC

[Deep Lens @deeplens_ai]

In 2017, the pathology innovator, pitched Simon, the serial analytics and AI entrepreneur and TJ, the cancer genetics PhD and strategy consultant, on the idea of a new company. This is how Deep Lens was founded. Learn more here: https://t.co/DMhFroqNIs
#DeepLens #HealthTech

[Deep Lens @deeplens_ai]

VIPER optimizes the enrollment process to help you capture more patients, but how does it work? Download our infographic here to learn more: https://t.co/mQNJqALhwT

#ClinicalTrial #PatientRecruitment #VIPER

[Deep Lens @deeplens_ai]

|| Download || By identifying patients at the time of diagnosis, our advanced AI-enabled patient recruitment platform compresses study timelines by finding the best-suited patients for clinical trials. Download our brochure to learn more...

https://t.co/plG3OHCQf5

[Deep Lens @deeplens_ai]

Our team is growing!
If you’re looking for a new challenge in an innovative, high-energy environment, check out our current openings to see if there might be a match.
#engineer #healthcare #career #jobs #employment #devops #agile
https://t.co/ejGOqjNTn3

[Deep Lens @deeplens_ai]

|| Download || By identifying patients at the time of diagnosis, our advanced AI-enabled patient recruitment platform compresses study timelines by finding the best-suited patients for clinical trials. Download our brochure to learn more...

https://t.co/FkvVjDotTZ

[Deep Lens @deeplens_ai]

|| Download || By identifying patients at the time of diagnosis, our advanced AI-enabled patient recruitment platform compresses study timelines by finding the best-suited patients for clinical trials. Download our brochure to learn more...

https://t.co/VDHE96NXDh

[Deep Lens @deeplens_ai]

"It is estimated that cancer therapies take 30%-40% longer than other indications to gain approval"

Discover what T.J. Bowen has to say in his interview with @InterventOnc360 here: https://t.co/DnmhZS5m5q

[Deep Lens @deeplens_ai]

It's estimated that less than 5% of eligible adult patients enroll in clinical trials. With approximately 15,000 oncology trials actively recruiting patients, it's essential to look at new technologies that could help.

https://t.co/alB6HzxbrG #AI #ClinicalTrials #Oncology

[Deep Lens @deeplens_ai]

|| Download || By identifying patients at the time of diagnosis, our advanced AI-enabled patient recruitment platform compresses study timelines by finding the best-suited patients for clinical trials. Download our brochure to learn more...

https://t.co/phUgPnRfaV

[Deep Lens @deeplens_ai]

Our team is growing!
If you’re looking for a new challenge in an innovative, high-energy environment, check out our current openings to see if there might be a match.
#engineer #healthcare #career #jobs #employment #devops #agile
https://t.co/6aUDb8dxwW

[Deep Lens @deeplens_ai]

Matching the right patient with the right trial at the right time - Discover how VIPER can help you ....

#clinicaltrials  #clinicalresearch #precisiononcology #moleculardiagnostics #patientrecruitment #clinicalstudies

https://t.co/gVypY71B0u

[Deep Lens @deeplens_ai]

|| Download || By identifying patients at the time of diagnosis, our advanced AI-enabled patient recruitment platform compresses study timelines by finding the best-suited patients for clinical trials. Download our brochure to learn more...

https://t.co/YniyKdfvoy